W Shon, SD Billings - Advances in anatomic pathology, 2019 - journals.lww.com
Vascular tumors are a diagnostically challenging area. This is particularly true in the case of epithelioid vascular tumors. Not only is the distinction between different epithelioid vascular …
NP Agaram, L Zhang, P Cotzia… - The American journal of …, 2018 - journals.lww.com
Pseudomyogenic hemangioendothelioma (PHE) is an uncommon, rarely metastasizing vascular neoplasm with predilection to affect young adults. The tumors often present as …
Purpose: Pseudomyogenic hemangioendothelioma (PHE) is an extremely rare locally aggressive neoplasm with endothelial differentiation, which often presents with multiple …
D Pradhan, K Schoedel, RL McGough, S Ranganathan… - Human Pathology, 2018 - Elsevier
Pseudomyogenic hemangioendothelioma (PHE) is an uncommon neoplasm with propensity for local recurrence. The tumor mimics epithelioid hemangioendothelioma and epithelioid …
N Yang, Y Huang, P Yang, W Yan, S Zhang, N Li… - Diagnostic …, 2023 - Springer
Objectives Pseudomyogenic hemangioendothelioma (PHE) is a rare intermediate hemangioendothelioma. This article aims to study the clinicopathological features of PHE …
A Al-Qaderi, AT Mansour - Archives of Pathology & …, 2019 - meridian.allenpress.com
First described in 2003 as epithelioid-sarcoma-like hemangioendothelioma and later in 2011 as pseudomyogenic hemangioendothelioma, this rare vascular tumor is of …
SLM Ong, K Szuhai, JVMG Bovée - Expert review of molecular …, 2021 - Taylor & Francis
Introduction The group of vascular tumors contains many different entities, and is considered difficult by pathologists, as they often have overlapping histological characteristics …
Chromosomal translocations are prevalent among soft tissue tumors, including those of the vasculature such as pseudomyogenic hemangioendothelioma (PHE). PHE shows …
I Tortorelli, E Bellan, B Chiusole, F Murtas… - Critical Reviews in …, 2024 - Elsevier
Primary vascular tumors of bone are a heterogeneous group of neoplasms, ranging from benign hemangiomas to frankly malignant epithelioid hemangioendotheliomas and …